Certara (CERT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Q1 2026 revenue was $106.9 million, up 1% year-over-year, driven by 7% software growth and a 4% decline in services revenue.
Net loss was $8.8 million, compared to net income of $4.7 million in Q1 2025, due to higher operating expenses and tax costs.
Completed divestiture of the Regulatory and Medical Writing business for up to $135 million, shifting revenue mix to about 50% software and 50% services.
Strategic AI initiatives included appointing a Chief AI Officer, collaboration with NVIDIA, and reorganization into two growth areas.
$40 million in share repurchases during Q1; $82.6 million repurchased since authorization.
Financial highlights
Software revenue grew 7% to $49.7 million; software bookings rose 20% to $48.7 million.
Services revenue declined 4% to $57.2 million; services bookings fell 14% to $66.6 million.
Adjusted EBITDA was $31.7 million (30% margin), down from $34.8 million last year.
Adjusted net income was $14.5 million, down from $22.2 million in Q1 2025.
Diluted loss per share was $0.06; adjusted diluted EPS was $0.09, down from $0.14.
Outlook and guidance
2026 full-year revenue expected at $395–$405 million, including $18 million from divested business; ex-divestiture, growth expected at 0–4%.
Adjusted EBITDA margin projected at 30–32%; adjusted EPS guidance is $0.35–$0.41.
Revenue mix expected to shift to approximately 50% software and 50% services.
Fully diluted shares expected at 157–159 million; tax rate at 30%.
No formal forward-looking financial guidance provided for the remainder of 2026 in some disclosures.
Latest events from Certara
- FY 2025 revenue rose 9% to $418.8M, but 2026 outlook is flat as AI and operational changes continue.CERT
Q4 20259 Jul 2026 - Q1 2025 revenue up 10%, bookings up 12%, profitability returns, and $100M buyback announced.CERT
Q1 20258 Jul 2026 - Strategic realignment and AI integration drive growth and innovation across clinical development.CERT
Jefferies Global Healthcare Conference 20263 Jun 2026 - AI-driven innovation, regulatory support, and market momentum set the stage for double-digit growth.CERT
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - All proposals passed, including director elections and auditor ratification, in a virtual meeting.CERT
AGM 202615 May 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting topics.CERT
Proxy filing3 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.CERT
Proxy filing3 Apr 2026 - AI-driven product launches and disciplined cost control set the stage for cautious 2026 growth.CERT
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - 2026 guidance reflects stable markets, strong biosimulation growth, and operational transformation.CERT
Leerink Global Healthcare Conference 20269 Mar 2026